Montesino Ibelis 4
4 · HERBALIFE LTD. · Filed Mar 6, 2018
Insider Transaction Report
Form 4
Fleming Ibelis
SVP/Managing Dir North America
Transactions
- Exercise/Conversion
Common Stock
2018-03-02$30.44/sh+19,576$595,893→ 32,177 total - Tax Payment
Common Stock
2018-03-02$94.72/sh−5,032$476,631→ 20,853 total - Sale
Common Stock
2018-03-06$94.63/sh−8,252$780,887→ 4,634 total - Exercise/Conversion
Stock Appreciation Rights
2018-03-02−19,576→ 0 totalExercise: $30.44From: 2018-03-02Exp: 2025-03-02→ Common Stock (19,576 underlying) - Disposition to Issuer
Common Stock
2018-03-02$94.72/sh−6,292$595,978→ 25,885 total - Sale
Common Stock
2018-03-02$93.02/sh−7,967$741,090→ 12,886 total
Footnotes (3)
- [F1]The reporting person received 8,252 shares of common stock upon the net exercise of the 19,576 SARs. The reporting person forfeited 6,292 shares of common stock underlying the SARs in payment of the exercise price and 5,032 shares of common stock underlying the SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on March 2, 2018 of $94.72.
- [F2]This transaction was executed in multiple trades at prices ranging from $92.89 to $93.18. The price reported reflects the weighted average sale price of $93.02. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $94.50 to $94.95. The price reported reflects the weighted average sale price of $94.63. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.